Inhaled Low‐Dose Iloprost for Pulmonary Hypertension: A Prospective, Multicenter, Open‐Label Study

BACKGROUND: Inhaled iloprost (average >30 µg/d) has been considered an effective treatment for severe pulmonary hypertension (PH). Further evidence also showed that low‐dose iloprost given intravenously was equally effective as high‐dose iloprost in the therapy of systemic sclerosis. HYPOTHESIS:...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cardiol
Main Authors: Sun, Yun‐Juan, Xiong, Chang‐Ming, Shan, Guang‐Liang, Gu, Qing, Zeng, Wei‐Jie, Lu, Xian‐Ling, Zhu, Feng, Liu, Zhi‐Hong, Ni, Xin‐Hai, He, Jian‐Guo
Format: Artigo
Sprog:Inglês
Udgivet: Wiley Periodicals, Inc. 2012
Fag:
Clinical Investigations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652663/
https://ncbi.nlm.nih.gov/pubmed/22488211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.21987
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker